These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9611324)

  • 1. [Selective intra-arterial use of small doses of thienam and vasaprostanin the treatment of suppurative diseases of the foot in patients with diabetes mellitus].
    Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
    Vestn Khir Im I I Grek; 1998; 157(1):76-7. PubMed ID: 9611324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus].
    Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
    Klin Khir; 1998; (8):53. PubMed ID: 9866335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic].
    Briskin BS; Khachatrian NN; Nekrasova NI; Kuznetsov EV; Suplotova AA; Sosnovikova OG
    Khirurgiia (Mosk); 2000; (9):56-61. PubMed ID: 11026205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of antibiotic thienam in critical care patients].
    Mariutin PV; Uchvatkin VG
    Anesteziol Reanimatol; 1995; (4):67-8. PubMed ID: 7486202
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prolonged intraarterial medicinal therapy of the destructive forms of diabetic foot syndrome].
    Antoniuk SM; Sviridov MV; Andrienko IB; Karabak SG; Barkalov SV
    Klin Khir; 2005 Sep; (9):26-8. PubMed ID: 16445040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of imipenem/cilastatin (thienam) against agents causing pyoseptic processes].
    Vasina TA; Kartavenko VI; Men'shikova ED; Shabanov AK; Mironov AV
    Khirurgiia (Mosk); 2002; (12):45-7. PubMed ID: 12522928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aprostan application in the treatment of the diabetic foot, atherosclerotic arterial lesions in the stage of critical ischemia].
    Mishalov VH; Seliuk VM; Cherviak VA; Litvinova NIu
    Klin Khir; 2001 Aug; (8):66-7. PubMed ID: 11794125
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case with severe acute pancreatitis treated by regional arterial infusion of nafamostat mesilate and imipenem via both celiac artery and superior mesenteric artery].
    Imamura T; Yoshida H; Ishikawa A; Katayose K; Nozu F; Kitamura K; Ikegami A; Takahashi A; Niikawa J; Tanaka S; Ishii H; Hoshino M; Kusano M; Matsui S; Hashimoto T; Mitamura K
    Nihon Shokakibyo Gakkai Zasshi; 2002 Sep; 99(9):1097-102. PubMed ID: 12355899
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical efficacy of alprostan in combination with "Bioptron-II" rays and iruxol-miramistin in the treatment of the diabetic foot complicated by atherosclerosis].
    Tomashuk IP; Tomashuk II
    Klin Khir; 2001 Aug; (8):49-51. PubMed ID: 11794113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
    Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract]   [Full Text] [Related]  

  • 12. TREATMENT OF PYOINFLAMMATORY COMPLICATIONS WITH INDIVIDUALLY SELECTED OZONE DOSE IN PATIENTS WITH DIABETES.
    Karatieieva S; Makarova O; Yurkiv O; Semenenko S; Berezova M
    Georgian Med News; 2018 Feb; (Issue):91-94. PubMed ID: 29578432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of radiotherapy in the complex treatment of patients with complicated forms of diabetic angiopathy].
    Chaĭka OO
    Klin Khir; 1997; (9-10):27-8. PubMed ID: 9511320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vision in patients with the diabetic foot during the treatment with alprostan].
    Veselovskaia NN
    Klin Khir; 2001 Aug; (8):61-2. PubMed ID: 11794121
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex approach to the treatment of suppurative lesions of the foot in patients with diabetes mellitus].
    Dekhtiar' AL; Antsyshovich EA; Kalyshev IuG; Gorin VV; Pilipeev IG
    Klin Khir; 1995; (7-8):39-40. PubMed ID: 8624938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with the therapy of acute finger ischemia by high-dose intra-arterial infusion of PGE1 through a surgically introduced catheter].
    Altstaedt HO
    Chirurg; 1999 Oct; 70(10):1144-8. PubMed ID: 10550345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative therapy of tissue decubitus in a combined therapy of patients with obliterating disease and diabetes-related vascular injuries].
    Michalov VG; Seliuk VM; Cherniak VA; Osadchiĭ AI; Litvinova NIu
    Klin Khir; 2002; (11-12):47-8. PubMed ID: 12549284
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of thienam for the emergency antibacterial therapy of acute suppurative pyelonephritis].
    Pasiechnikov SP; Pohrebyns'kyĭ VM; Rudenko AV; Mitchenko MV
    Lik Sprava; 1997; (1):84-7. PubMed ID: 9221156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
    Tsukada T; Katayama N; Kageyama S; Nishikawa M; Kobayashi T; Deguchi K; Shirakawa S; Minami N
    Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.